Management of Elevated INR in Patients with Prosthetic Heart Valves

Immediate Assessment and Management

The American College of Cardiology recommends evaluating patients with prosthetic heart valves and elevated INR for signs of bleeding, including gross hemorrhage, occult bleeding, and intracranial hemorrhage symptoms, and assessing bleeding risk factors such as advanced age, renal insufficiency, and history of gastrointestinal bleeding or stroke 2, 3
For patients with prosthetic heart valves and INR of 5.96 without active bleeding, the European Heart Journal suggests immediately holding warfarin and administering oral vitamin K 2.5-5 mg, with INR rechecked within 24 hours 1, 2, 6
The American College of Cardiology guidelines state that mitral mechanical valves carry a higher thrombotic risk than aortic valves, influencing thrombosis risk during anticoagulation interruption 4, 5

The European Heart Journal recommends that the risk of major bleeding rises considerably when INR exceeds 4.5 and exponentially above 6.0, requiring reversal of anticoagulation 6, 1
For patients with prosthetic heart valves and elevated INR without active bleeding, the American College of Cardiology suggests stopping warfarin immediately and administering oral vitamin K1 2.5-5 mg, with expected INR reduction within 24-48 hours 1, 2, 6
In patients with prosthetic heart valves, intravenous vitamin K should not be used due to the risk of valve thrombosis from rapid INR reduction, according to the European Heart Journal 6, 1

The American College of Cardiology recommends resuming warfarin at a lower dose than previously required once INR normalizes and bleeding risk is controlled, and considering bridging with heparin if the patient is at high thrombotic risk 3, 5
The target INR for mechanical aortic valve is 2.5 (range 2.0-3.0) for current-generation bileaflet valves without additional risk factors, according to the American College of Cardiology 4, 5
The target INR for mechanical mitral valve is 3.0 (range 2.5-3.5) for all mechanical valves, as recommended by the American College of Cardiology 4, 5

The American College of Cardiology suggests identifying precipitating factors for elevated INR, including drug interactions, dietary changes, acute illness or infection, liver dysfunction, or heart failure decompensation 1, 2, 3

The European Heart Journal warns against using high-dose vitamin K (>10 mg) routinely, as it can create warfarin resistance and induce a hypercoagulable state 5, 2
The American College of Cardiology recommends never using IV vitamin K in stable prosthetic valve patients due to the risk of valve thrombosis from rapid overcorrection 6, 1, 2

The American College of Cardiology suggests rechecking INR within 24 hours after vitamin K administration, and once warfarin is restarted, checking INR every 2-3 days initially until stable in therapeutic range 1, 2
The American College of Cardiology recommends maintaining more frequent INR monitoring (weekly) for several weeks after this episode given demonstrated instability 4